Table 4.
ASAQ | AL | p* | |
---|---|---|---|
(n = 1060) | (n = 770) | ||
n (%) | n (%) | ||
Proportion of adherent patients | 1003 (94.6) | 742 (96.4) | 0.08 |
Reported side effects | 361 (34.1) | 68 (8.8) | < 0.001 |
Vomiting | 57 (5.4) | 22 (2.9) | 0.009 |
Fatigue | 287 (27.1) | 14 (1.8) | < 0.001 |
Dizziness | 42 (4.0) | 10 (1.3) | 0.001 |
Gastro-intestinal trouble | 47 (4.4) | 23 (3.0) | 0.11 |
Drowsiness | 50 (4.7) | 6 (0.8) | < 0.001 |
Other side effecta | 14 (1.3) | 5 (0.6) | < 0.16 |
* χ2 test
aAnorexia (n = 4), ringing in the ears (n = 3), facial puffiness (n = 2), insomnia (n = 1), cough (n = 1), itch (n = 1), headache (n = 2), fever (n = 1), chills (n = 4)